Difelikefalin: A CE Certified Pain Relief Medication

Hybio Pharmaceutical Co., Ltd. is proud to introduce Difelikefalin, a groundbreaking pharmaceutical product that has recently obtained CE certification. Difelikefalin is a novel, non-opioid, highly selective, and potent peptide designed to provide effective pain relief for patients suffering from chronic kidney disease-associated pruritus (CKD-aP), With the CE certification, Difelikefalin has been recognized for its compliance with European health, safety, and environmental protection standards, ensuring its quality, safety, and performance. This certification further validates the efficacy and safety of Difelikefalin, making it a reliable and trusted option for healthcare professionals and patients in Europe, Hybio Pharmaceutical Co., Ltd. is committed to delivering innovative and high-quality pharmaceutical solutions, and Difelikefalin is a testament to that commitment. As we continue to expand our global presence, obtaining the CE certification for Difelikefalin demonstrates our dedication to meeting the highest regulatory standards and providing valuable treatment options for patients in need, We are excited to bring Difelikefalin to the European market and are confident that it will make a positive impact on the lives of CKD-aP patients